Breast cancer,characterized by unique epidemiological patterns and significant heterogeneity,remains one of the leading causes of malignancy-related deaths in women.The increasingly nuanced molecular subtypes of breas...Breast cancer,characterized by unique epidemiological patterns and significant heterogeneity,remains one of the leading causes of malignancy-related deaths in women.The increasingly nuanced molecular subtypes of breast cancer have enhanced the comprehension and precision treatment of this disease.The mechanisms of tumorigenesis and progression of breast cancer have been central to scientific research,with investigations spanning various perspectives such as tumor stemness,intra-tumoral microbiota,and circadian rhythms.Technological advancements,particularly those integrated with artificial intelligence,have significantly improved the accuracy of breast cancer detection and diagnosis.The emergence of novel therapeutic concepts and drugs represents a paradigm shift towards personalized medicine.Evidence suggests that optimal diagnosis and treatment models tailored to individual patient risk and expected subtypes are crucial,supporting the era of precision oncology for breast cancer.Despite the rapid advancements in oncology and the increasing emphasis on the clinical precision treatment of breast cancer,a comprehensive update and summary of the panoramic knowledge related to this disease are needed.In this review,we provide a thorough overview of the global status of breast cancer,including its epidemiology,risk factors,pathophysiology,and molecular subtyping.Additionally,we elaborate on the latest research into mechanisms contributing to breast cancer progression,emerging treatment strategies,and long-term patient management.This review offers valuable insights into the latest advancements in Breast Cancer Research,thereby facilitating future progress in both basic research and clinical application.展开更多
基金supported by the National Key R&D Program of China(grant number:2023YFC3404100,2023YFC2506400)National Natural Science Foundation of China(grant number:82325042,82203860)+1 种基金Shanghai Municipal Education Commission Scientific Research Innovation Project(grant number:2023-05-50)Wu Jieping Medical Foundation Research Project(grant number:32067502023-18-29).
文摘Breast cancer,characterized by unique epidemiological patterns and significant heterogeneity,remains one of the leading causes of malignancy-related deaths in women.The increasingly nuanced molecular subtypes of breast cancer have enhanced the comprehension and precision treatment of this disease.The mechanisms of tumorigenesis and progression of breast cancer have been central to scientific research,with investigations spanning various perspectives such as tumor stemness,intra-tumoral microbiota,and circadian rhythms.Technological advancements,particularly those integrated with artificial intelligence,have significantly improved the accuracy of breast cancer detection and diagnosis.The emergence of novel therapeutic concepts and drugs represents a paradigm shift towards personalized medicine.Evidence suggests that optimal diagnosis and treatment models tailored to individual patient risk and expected subtypes are crucial,supporting the era of precision oncology for breast cancer.Despite the rapid advancements in oncology and the increasing emphasis on the clinical precision treatment of breast cancer,a comprehensive update and summary of the panoramic knowledge related to this disease are needed.In this review,we provide a thorough overview of the global status of breast cancer,including its epidemiology,risk factors,pathophysiology,and molecular subtyping.Additionally,we elaborate on the latest research into mechanisms contributing to breast cancer progression,emerging treatment strategies,and long-term patient management.This review offers valuable insights into the latest advancements in Breast Cancer Research,thereby facilitating future progress in both basic research and clinical application.
